American Academy of Dermatology

Compared to standard cleansers and moisturizers, natural versions for sensitive skin provided benefits to patients with rosacea who were also taking prescription treatments.

In this analysis, brodalumab was successful in treating patients who had a psoriasis diagnosis for

New data from AAD show the recently-approved biologic is among the most cost-saving therapies in year 2 of treatment, and beyond.

Investigators sought to evaluate the efficacy, safety, psychosocial impact, quality of life, adherence to and satisfaction with the treatment of dupilumab and add-on treatment.

An internist’s perspective on which sessions to attend, from melanoma to inflammatory diseases to cosmetic procedures.

A meta-analysis of studies found that treatment with platelet-rich plasma improves androgenetic alopecia, scarring, and other dermatologic conditions.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

While several new treatment options for plaque psoriasis and psoriatic arthritis have launched in recent years, there is still much work to be done in the field to help patients through long stretches of care.

The array of medications and treatments for plaque psoriasis and psoriatic arthritis continues to expand, giving doctors and patients more choices when deciding on a management plan.

A lot of work goes into a medication being approved for the public including many rounds of trials and adjustments along the way. For a new plaque psoriasis medication that work is well underway and the developers hope to have it to patients in the near future.

The development of new medications to help patients with plaque psoriasis seems to take steps forward on a daily basis. Results presented at a recent conference showed at least one could help provide much needed relief for this patient group.

Understanding the difference between clear and almost clear skin is crucial with the advent of new biologic therapies that make complete clearance attainable.

Psoriasis treatment in the geriatric demographic has long been poorly understood.

Whether it is sitting at the beach, working in the yard or just walking to the grocery store, the risk of developing skin cancer is a risk for everyone. A recent study looked at the impact of the sun particularly for asian and hispanic people.

The treatment of vitiligo has come a long way in recent years and there is already work being done to improve treatment in the future.

When treating a patient with vitiligo it can be easy to look at their skin condition and no further. There is work being done to show that more can be done to help the patient not only physically, but mentally as well.

Dermira, Inc. presented clinical data from its successful DRM01 Phase 2a trial in patients with facial acne vulgaris at the American Academy of Dermatology (AAD) Annual Meeting on March 20, 2015 in San Francisco.

In most instances a microscope is enough to make a diagnosis of melanoma, but in some the view under the lens does not provide a clear enough picture. A new test that combines math and science could make the most difficult cases easier to identify.

For anyone who has had or been exposed to someone with chicken pox herpes zoster, or shingles, can be a very real risk. A vaccine for patients over the age of 60 can greatly reduce the likelihood of contracting the disease.

The American Academy of Dermatology is meeting in San Francisco and while there are many noteworthy topics being discussed, melanoma is one of the leading topics of discussion at the event.

Novartis announced results from the CLEAR study demonstrating Cosentyxâ„¢ (secukinumab) improved skin clearance at Week 16 in significantly more moderate-to-severe plaque psoriasis patients compared to Stelara®* (ustekinumab), a widely used biologic.